Welcome to Vivendy Therapeutics

Vivendy Therapeutics Ltd. was founded in March 2006, as a spin-off of Inotech Biotechnologies AG. The company's mission is the development of an enzyme replacement therapy (ERT) for Morbus Morquio (Mucopolysaccharidosis (MPS IVA), a rare lysosomal storage disease (LSD)